21 March 2019

Bart Kiemeney will step down as director of the Radboud Institute for Health Sciences (RIHS) on 1 April. Bart has held this position for over seven years and has brought the quality of science Radboudumc-wide to a higher level. The Board of Directors is very grateful to him for his tireless efforts for high-quality and socially relevant health (care) research.

After 1 April Bart will again focus on conducting his own research within his area of ​​expertise and on teaching. We would like to give you the opportunity to say goodbye to Bart as director of the institute during the Radboud Research Round with theme Urological Cancers.

Thursday 28 March 2019
16.00 - 17.00 hrs  Radboud Research Round Theme Urological cancers
17.00 - 17.15 hrs  Looking back by Paul Smits and Bart Kiemeney
17.15 - 18.30 hrs  Research Café 


Your presence will be highly appreciated! Please send an e-mail to rihs@radboudumc.nl if you want to be present.  

 

Related news items


Internal KWF review procedure 2020

13 June 2019

In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications.

read more

Peter van der Kraan new theme leader Inflammatory diseases

13 June 2019

It is our pleasure to introduce Peter van der Kraan from the Dept. of Rheumatology, as the new leader of our theme Inflammatory diseases. As such he will be the successor of Irma Joosten who has done an outstanding job in the last years as theme leader, for which we thank her wholeheartedly.

read more

RIHS PhD candidates visit Philips Healthcare

13 June 2019

On 7 June the RIHS PhD council organized an excursion to Philips Healthcare in Best.

read more

Intake of a reduced dose of pazopanib with food the effect on pharmacokinetics, patient safety and preference

13 June 2019

In Clinical Pharmacology & Therapeutics Floor Lubberman and colleagues showed that the intake of 600mg pazopanib with food resulted in a bioequivalent exposure and was preferred over a standard pazopanib dose without food.

read more

Developing malaria gametocytes under attack

6 June 2019

In Science Translational Medicine, researchers from the group of Teun Bousema and international colleagues have revealed previously unknown targets of natural human antibody responses that are found on the surfaces of red blood cells infected with malaria parasites.

read more

The XN-30 hematology analyzer for rapid sensitive detection of malaria a diagnostic accuracy study

6 June 2019

In BMC Medicine Annelies Post, Berenger Kaboré, Isaie Reuling and colleagues described a new method of malaria detection using whole blood: the XN-30 is a new hematology analyzer which simultaneously provides a complete blood count and quantification of malaria parasitemia, allowing rapid treatment.

read more